A pivotal decade for bispecific antibodies?
ABSTRACTBispecific antibodies (bsAbs) are a class of antibodies that can mediate novel mechanisms of action compared to monospecific monoclonal antibodies (mAbs). Since the discovery of mAbs and their adoption as therapeutic agents in the 1980s and 1990s, the development of bsAbs has held substantia...
Saved in:
Main Authors: | Marlena Surowka (Author), Christian Klein (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ten years in the making: application of CrossMab technology for the development of therapeutic bispecific antibodies and antibody fusion proteins
by: Marlena Surowka, et al.
Published: (2021) -
Bispecific antibodies in cancer immunotherapy
by: Eva Dahlén, et al.
Published: (2018) -
Bispecific antibodies for viral immunotherapy
by: Elisabeth K. Nyakatura, et al.
Published: (2017) -
Developability considerations for bispecific and multispecific antibodies
by: Alaa Amash, et al.
Published: (2024) -
Bispecific Antibodies Progression in Malignant Melanoma
by: Juan Tang, et al.
Published: (2022)